17:31 , Jan 11, 2019 |  BC Week In Review  |  Financial News

Frequency raises $42M series B

Regenerative medicine company Frequency Therapeutics Inc. (Woburn, Mass.) raised $42 million on Jan. 7 in a series B round led by Taiwania Capital Management. Also participating were new investors Yonjin Capital and DF Investments and...
00:39 , Jan 5, 2019 |  BioCentury  |  Finance

Longitude takes a spin with Cydan

Longitude Capital's first foray into a Cydan Development Inc. spinout came Thursday when Cydan launched Tiburio Therapeutics Inc. to repurpose TBR-760 (formerly BIM-23A760) from Ipsen Group (Euronext:IPN; Pink:IPSEY), eight years after the compound's false start...
19:08 , Jan 4, 2019 |  BC Week In Review  |  Financial News

Cydan spins out rare endocrine company Tiburio with $31M, Ipsen compounds

Tiburio Therapeutics Inc. (Cambridge, Mass.) launched Jan. 3 with a $31 million series A round and two clinical compounds licensed from Ipsen Group (Euronext:IPN; Pink:IPSEY) that it plans to develop for rare neuroendocrine tumors and...
12:06 , Jan 3, 2019 |  BC Extra  |  Financial News

Cydan spins out rare endocrine company Tiburio with $31M, Ipsen compounds

Tiburio Therapeutics Inc. (Cambridge, Mass.) launched Thursday with a $31 million series A round and two clinical compounds licensed from Ipsen Group (Euronext:IPN; Pink:IPSEY) that it plans to develop for rare neuroendocrine tumors and rare...
19:28 , Dec 21, 2018 |  BC Week In Review  |  Financial News

Relay runs away with $400M series C on back of protein conformation platform

Protein motion company Relay Therapeutics Inc. (Cambridge, Mass.) raised $400 million on Dec. 20 in an untranched series C led by new investor SoftBank Vision Fund. Relay President and CEO Sanjiv Patel told BioCentury the...
12:00 , Dec 20, 2018 |  BC Extra  |  Financial News

Relay runs away with $400M series C on back of protein conformation platform

Protein motion company Relay Therapeutics Inc. (Cambridge, Mass.) raised $400 million in an untranched series C led by new investor SoftBank Vision Fund. Relay President and CEO Sanjiv Patel told BioCentury the round will provide...
19:02 , Dec 7, 2018 |  BC Week In Review  |  Financial News

Gates leads Kallyope's $21M B round expansion

Bill Gates has joined an existing investor syndicate to lead a $21 million expansion of a series B round for Kallyope Inc. (New York, N.Y.). Kallyope has now raised $87 million in the round and...
19:45 , Dec 5, 2018 |  BC Extra  |  Financial News

Gates leads Kallyope's $21M B round expansion

Bill Gates has joined an existing investor syndicate to lead a $21 million expansion of a series B round for Kallyope Inc. (New York, N.Y.). Kallyope has now raised $87 million in the round and...
18:29 , Nov 30, 2018 |  BC Week In Review  |  Financial News

Neurodegeneration play Rheostat raises $23M series A

Rheostat Therapeutics (Cambridge, Mass.) raised $23 million in a series A round to bring its first programs in neurodegenerative disease to IND. The round was co-led by MRL Ventures Fund and AbbVie Ventures, with participation...
00:06 , Nov 27, 2018 |  BC Extra  |  Financial News

Neurodegeneration play Rheostat raises $23M series A

Rheostat Therapeutics (Cambridge, Mass.) raised $23 million in a series A round to bring its first programs in neurodegenerative disease to IND. The round was co-led by MRL Ventures Fund and AbbVie Ventures, with participation...